Literature DB >> 13962891

Antinuclear factor in myasthenia gravis.

T E FELTKAMP, K KRUYFF, H J OOSTERHUIS.   

Abstract

Entities:  

Keywords:  ANTIBODIES; CELL NUCLEUS; MYASTHENIA GRAVIS

Mesh:

Substances:

Year:  1963        PMID: 13962891     DOI: 10.1016/s0140-6736(63)91302-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  MYASTHENIA GRAVIS WITH HYPERGAMMAGLOBULINAEMIA AND ANTIBODIES.

Authors:  H J OOSTERHUIS; H VAN DER GELD; T E FELTKAMP; F PEETOOM
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-08       Impact factor: 10.154

2.  IMMUNOLOGICAL DISTURBANCES IN MYASTHENIA GRAVIS WITH A REPORT OF HASHIMOTO'S DISEASE DEVELOPING AFTER THYMECTOMY.

Authors:  J A SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-12       Impact factor: 10.154

3.  AUTOIMMUNITY IN MYASTHENIA GRAVIS.

Authors:  M THIERY
Journal:  Br Med J       Date:  1965-04-03

Review 4.  [The pathogenesis of myasthenia gravis as an immunological problem].

Authors:  J R Kalden
Journal:  Klin Wochenschr       Date:  1970-01-01

5.  Autoimmunity in myasthenia gravis: a family study.

Authors:  R Wright; J H Kerr
Journal:  Clin Exp Immunol       Date:  1967-01       Impact factor: 4.330

6.  Autoantibodies found after thymectomy in a patient later developing myasthenia gravis.

Authors:  J H Kerr; C G Duran; H Thomas; R Wright
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-10       Impact factor: 10.154

7.  Endocrine function of the thymus affecting neuromuscular transmission.

Authors:  G Goldstein; W W Hofmann
Journal:  Clin Exp Immunol       Date:  1969-02       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.